Scholars Central

Conference abstract

Multifunctional polycyclic amines as antimycobacterials: Exploring mechanism of action and resistance reversal possibilities in Mycobacterium tuberculosis

Authors: Erika Kapp

Abstract

Ever-increasing levels of drug resistance in Mycobacterium tuberculosis necessitate novel approaches in the search for new antimycobacterials. Early identification of likely mechanism of action and probability of successful accumulation of potential antimycobacterials within mycobacterial cells allow for triage of compounds that warrant further investigation. Early knowledge pertaining to novelty of mechanism of action, possible cross resistance to existing antimycobacterials as well as the risk of acquisition of genetic resistance brought on by effluxmediated sub-therapeutic intracellular compound accumulation, promotes the likelyhood of identification of therapeutically viable antimycobacterials. Antimycobacterial activity as well as synergistic activity in combination with known antimycobacterials was evaluated for a range of polycyclic amine derivatives obtained from the School of Pharmacy compound library. Compounds were selected based on presence of pharmacophoric moieties for antimycobacterial activity, the inclusion of bulky lipophilic carriers to promote intracellular accumulation through increased cell wall penetration or alternatively reduced efflux as well as previously demonstrated bioactivity that may support accumulation of coadministered compounds within mycobacterial cells. The most active compound demonstrated a MIC99 of 9.6 μM against Mycobacterium tuberculosis H37Rv. Genotoxicity and inhibition of the problematic bc1 respiratory complex was excluded as mechanism for all compounds, with the two most active compounds likely inhibiting cell wall synthesis in a fashion similar to ethambutol. Synergism assays with known antimycobacterials are currently underway and preliminary results indicate possible synergistic activity with known antimycobacterials. Further structure activity relationship analysis will inform the development of compounds with increased potency and selectivity while exploring possible resistance reversal activity.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases and Treatment
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Erika Kapp”